Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCHAL.L Regulatory News (CHAL)

  • There is currently no data for CHAL

Company Update - Additional Funds Received

6 Jun 2019 07:00

RNS Number : 2772B
Challenger Acquisitions Limited
06 June 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

 

For immediate release 6 June 2019

Challenger Acquisitions Limited

("Challenger" or the "Company")

 

Additional Funds Received

 

Challenger Acquisitions Limited (LSE: CHAL) announces that it has received a further US$50,750 (US$50,000 principal plus interest) pursuant to an agreement with the developers of the wheel project in Dallas, Texas to sell its US$300,000 investment in this project back to the Developers. This is the fifth of six scheduled payments.

 

**ENDS**

 

For more information visit www.challengeracquisitions.com or enquire to:

 

Challenger Acquisitions Limited

 

Mark Gustafson

 

+1 604 454 8677

St Brides Partners Ltd (PR)

 

Cosima Akerman

+44 (0) 20 7236 1177

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUVRVRKSANRAR
Date   Source Headline
17th May 20167:00 amRNSResult of AGM
16th May 20167:00 amRNSPurchase of Shares by Director
9th May 20167:00 amRNSPurchase of Shares by Director
3rd May 20167:00 amRNSPurchase of Shares by Director
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 20164:50 pmRNSAnnual Report and Notice of AGM
27th Apr 20167:00 amRNSFinal Results
26th Apr 20167:00 amRNSConvertible Notes Extension & Issue of £0.5m Note
13th Apr 20162:00 pmRNSAllotment of Shares re Convertible Loan Notes
31st Mar 20167:00 amRNSUpdate on Global Giant Observation Wheel Activity
24th Mar 20165:48 pmRNSFurther Re: Conversion of Convertible Loan Notes
21st Mar 20167:00 amRNSConversion of Convertible Loan Notes
9th Mar 201612:35 pmRNSPresenting at Shares Investor Evening
3rd Mar 20167:00 amRNSIssue of £0.5m convertible notes
22nd Feb 20167:00 amRNSUpdate on Giant Observation Wheel in Jakarta
5th Feb 20167:00 amRNSHolding(s) in Company
29th Jan 20165:00 pmRNSTotal Voting Rights
29th Jan 20167:00 amRNSIncreases Investment in New York Wheel
15th Jan 20167:00 amRNSAppointment of Financial Adviser
12th Jan 20167:00 amRNSAppointment of New Directors
7th Jan 20163:51 pmRNSAllotment of Shares and Options Granted
8th Dec 20158:00 amRNSReadmission to trading on London Stock Exchange
8th Dec 20158:00 amRNSCancellation - Challenger Acquisitions Limited
2nd Dec 20152:11 pmRNSPublication of Prospectus & Expected Readmission
30th Oct 201511:52 amRNSTotal Voting Rights
10th Sep 20155:30 pmRNSGrant of Options and Prospectus Update
28th Aug 20153:33 pmRNSHalf Yearly Report
5th Aug 201512:42 pmRNSHolding(s) in Company
30th Jul 20152:55 pmRNSFunding update, grant of options & issue of equity
21st Jul 20151:14 pmRNSHolding(s) in Company
16th Jul 20158:00 amRNSAcquisition of Starneth Completed
7th Jul 201512:34 pmRNSIssue of Equity
27th May 20153:31 pmRNSHolding(s) in Company
26th May 20159:25 amRNSInvestment, LOI and suspension
26th May 20159:10 amRNSSuspension Challenger Acquisitions Limited
20th May 20157:00 amRNSFunding Update
13th May 20155:23 pmRNSHolding(s) in Company
28th Apr 20158:00 amRNSProposed funding: up to £3m via convertible notes
7th Apr 201510:10 amRNSUK Investor Show
2nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20154:35 pmRNSPrice Monitoring Extension
18th Mar 20158:00 amRNSCorporation Agreement with Starneth signed
19th Feb 20157:00 amRNSAdmission to Trading and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.